Clinical Trials Directory

Trials / Completed

CompletedNCT02759302

MRI on Persons With Mutations in POMT2 Gene (LGMD2N)

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

POMT2 mutation is known to cause Walker Warburg Syndrome and Muscle-Brain-Eye syndrome. Recently it has been connected to limb girdle muscular dystrophy (LGMD), a disorder characterized by muscle weakness and atrophy of the proximal muscles of the shoulder and pelvic girdles. LGMD is classified based on its inheritance pattern and genetic cause into more than 31 different types. LGMD with POMT2 mutations is a new phenotype - type 2N. Very few patients with the LGMD2N phenotype has been reported. In this study, the investigators examine five new cases with the LGMD phenotype. The primary aim is to examine the muscle involvement using MRI.

Conditions

Timeline

Start date
2016-04-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-05-03
Last updated
2017-04-11

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02759302. Inclusion in this directory is not an endorsement.